Humana’s margin repair looks painful
- Humana is built around Medicare Advantage, where it takes premiums and pays member medical bills.
- Q1 2026 showed stress: the Insurance benefit ratio was 89.4%, and management said Q2 could move above 91%.
- Membership growth is no longer clearly good news because new Individual MA members are running at a higher benefit ratio.
- CenterWell is growing, but Q1 2026 operating income fell 26.3% as costs rose.
- The possible recovery path is 2027 benefit cuts, but that could push members to rivals.
A fix that may shrink the base
Humana’s near-term setup is weak. The company is still a large Medicare insurer, but the main issue is simple: medical claims are eating too much of the premium dollars it collects. In Q1 2026, the Insurance benefit ratio was 89.4%. That means 89.4 cents of each premium dollar went to member benefits before normal operating costs.
The bear case got stronger because Humana is adding members while margins are falling. Individual Medicare Advantage membership rose by 1,177,500 members from March 31, 2025 to March 31, 2026. Yet management said new members, on average, have a higher benefit ratio than retained members. Growth that hurts profit is not the kind investors want.
The bull case is now mostly a 2027 story. On the Q1 2026 call, management signaled that benefit cuts are likely in 2027 Medicare Advantage bids. If Humana cuts benefits enough, keeps enough members, and moves margins back toward its target over time, the stock can recover. That is a narrow path because rivals can use richer benefits to win members away.
CenterWell does not fix the problem today. The segment’s Q1 2026 operating income fell 26.3%, and its operating cost ratio rose to 94.5%. Humana says the v28 risk model change, integration costs, and business mix are pressuring margins. That leaves both major segments under pressure at the same time.
Premiums in, claims out
Humana makes most of its money by selling health plans. The biggest pool is Medicare Advantage, a private plan option for people on Medicare. Humana gets premiums, including payments tied to government programs, and then pays doctors, hospitals, drug costs, and member benefits.
The key profit lever is the benefit ratio. A lower ratio means Humana keeps more premium dollars after paying medical costs. A higher ratio means claims are taking more of the money. In Q1 2026, the consolidated benefit ratio rose from 87.0% to 89.4% year over year, which is why the thesis is negative.
CenterWell is the services side. It includes pharmacy solutions, primary care, and home solutions. It serves Humana members and outside payors, but it is tied closely to the insurance book. The idea is to manage care better and lower costs over time.
That model breaks when funding, plan pricing, member mix, and medical use do not line up. Star Ratings pressure is also important because lower-rated Medicare Advantage plans can receive lower quality bonus payments from CMS. Humana’s filing says about 25% of its Medicare Advantage members were in plans rated 4-star or higher for 2025, down from 94% based on 2024 Star Ratings.
Medicare first, services second
Individual Medicare Advantage
This is Humana’s core product. It is also the main problem right now because Q1 2026 growth came with a higher benefit ratio for new members.
Group Medicare Advantage
These plans are sold through group accounts. Q1 2026 membership rose 27.3%, helped by the 2026 selling season.
Medicare stand-alone PDP
These are prescription drug plans for Medicare members. Q1 2026 membership rose 58.7%, but PDP and Part D economics are sensitive to federal benefit design.
Medicaid, state-based contracts, and military services
These government-linked lines add scale and contract revenue. They can carry different margin profiles than Medicare Advantage.
CenterWell pharmacy solutions
This business fills and manages prescriptions. In Q1 2026, higher specialty pharmacy volume helped revenue but also pressured the cost ratio.
CenterWell primary care and home solutions
These services are meant to improve care and lower medical use over time. Recent acquisitions, including MaxHealth, add growth but also bring integration costs.
Two segments, one big driver
The mix uses Q1 2026 external segment revenue from Humana’s Form 10-Q. Insurance is almost all of the external revenue base, while CenterWell is larger internally because it also sells services to Humana’s Insurance segment.
What could go wrong
Medical costs outrun pricing
High impact · High oddsHumana’s main risk is that claims keep rising faster than premiums and plan changes. The Q1 2026 Insurance benefit ratio was 89.4%, and management projected Q2 could be above 91%. If that happens, profit pressure gets worse before any 2027 fix can help.
2027 benefit cuts backfire
High impact · Medium oddsManagement has signaled that 2027 Medicare Advantage benefit cuts are likely. That could repair margins, but members may leave if rival plans offer better benefits. The risk is a smaller and weaker revenue base, not just a one-year reset.
Star Ratings bonus hit
High impact · High oddsHumana disclosed that about 25% of Medicare Advantage members were in plans rated 4-star or higher for 2025, compared with 94% based on 2024 Star Ratings. The company says this will hurt 2026 quality bonus payments unless its legal challenge or other actions help. Lower bonus dollars make pricing and benefits harder.
CenterWell margin reset
Medium impact · High oddsCenterWell is supposed to be Humana’s services growth engine, but Q1 2026 operating income fell 26.3%. The segment’s operating cost ratio rose to 94.5%, with pressure from the v28 risk model, specialty pharmacy mix, and acquisition costs. If mitigation work fails, CenterWell may be less valuable than investors hoped.
Reserves prove too low
Medium impact · Medium oddsHumana’s results depend on estimating medical claims that have happened but are not fully paid yet. Q1 2026 operating cash flow benefited from an increase in the IBNR balance. If cost trends are worse than reserved, later quarters can take the hit.
In one breath
What does Humana do?
Humana sells health insurance, mainly Medicare Advantage plans, and runs CenterWell healthcare services. CenterWell includes pharmacy, primary care, and home solutions.
Why is Humana under pressure?
Medical costs are taking a larger share of premium revenue. In Q1 2026, the Insurance benefit ratio was 89.4%, and management said Q2 could move above 91%.
What could improve the Humana story?
The clearest path is 2027 Medicare Advantage repricing and benefit cuts. The hard part is doing that without losing too many members to competitors.